Drugs / Heliox
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT04404816 | Jan 2017 → Dec 2018 | pulmonary immaturity, respiratory distress syndrome in premature infants | Poznan University of Medical Sciences | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT02135900 | Dec 2009 → Apr 2011 | obstructive sleep apnea syndrome | Northwell Health | Completed | No outcome recorded |
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT00116584 | Dec 2004 → Mar 2008 | bronchiolitis | University of Louisville | Completed | Met primary |
| Phase not applicable1 trial | ||||||
| — | NCT03217149 | Sep 2017 → Aug 2020 | pediatric acute respiratory distress syndrome | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Unknown | No outcome recorded |
| Comparator or background therapy3 trials | ||||||
| Phase 1/2 | NCT00788788 Comparator | Nov → Dec 2007 | — | University of Witten/Herdecke | Completed | No outcome recorded |
| Phase 3 | NCT03171142 Comparator | May 2015 → Aug 2016 | acute bronchiolitis, respiratory syncytial virus infectious disease | Wael Seliem | Completed | No outcome recorded |
| Phase 4 | NCT07424014 Comparator | Feb 2026 → May 2027 expected | — | Indiana University | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Heliox | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02135900 ↗ |
| Modality | Other / unclassified | “helium-oxygen therapy” PMID 22147778 ↗ Dec 2011 |
| Route | Inhaled | “After nebulization, humidified helium-oxygen or oxygen was delivered by HFNC.” PMID 22147778 ↗ Dec 2011 |